Harrow achieves record high with $99.3 million in Q3 revenue
HROW Harrow Inc
$30.36 +10.52%
View chart & analysis → - 1Harrow recorded $99.3 million in revenue for the third quarter.
- 2Harrow revenue increased 41% compared to the previous quarter in Q3.
- 3QUELL clinical trial results failed to demonstrate non-inferiority, the primary endpoint.
So what's the key point?
Harrow's third-quarter revenue reached a record high of $99.3 million. However, a trial to confirm the effectiveness of a drug did not achieve the intended results.
Source The Motley Fool +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.